Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Cassava Sciences Inc
Nieuws
Cassava Sciences Inc
SAVA
NAS
: SAVA
| ISIN: US14817C1071
30/04/2025
1,560 USD
(0,00%)
(0,00%)
30/04/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
21 maart 2024 ·
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
· Persbericht
13 maart 2024 ·
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
· Persbericht
29 februari 2024 ·
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
· Persbericht
16 februari 2024 ·
CASSAVA SCIENCES SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cassava Sciences To Contact Him Directly To Discuss Their Options
· Persbericht
9 februari 2024 ·
Cassava Sciences Shareholder Action Reminder
· Persbericht
3 november 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
· Persbericht
25 oktober 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
· Persbericht
18 oktober 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
· Persbericht
13 oktober 2023 ·
Thinking about buying stock in Outset Medical, Tempest Therapeutics, Cassava Sciences, Rivian Automotive, or Athersys?
· Persbericht
30 juli 2022 ·
CASSAVA SCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Cassava Sciences, Inc. - SAVA
· Persbericht
13 oktober 2021 ·
SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
· Persbericht
10 oktober 2021 ·
Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Cassava Sciences, Inc. Investors of Securities Fraud Class Action Lawsuit
· Persbericht
30 september 2021 ·
Pomerantz Law Firm Announces the Filing of a Class Action Against Cassava Sciences, Inc. and Certain Officers - SAVA
· Persbericht
28 september 2021 ·
SAVA EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Cassava Sciences, Inc.
· Persbericht
23 september 2021 ·
SAVA INVESTOR LAWSUIT DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc.
· Persbericht
16 september 2021 ·
HAGENS BERMAN Encourages Cassava Sciences (SAVA) Investors with Significant Loss to Contact Firm's Attorneys Now, SAVA Reportedly Shifts Defense Against Claims of Scientific Misconduct
· Persbericht
14 september 2021 ·
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA)
· Persbericht
12 september 2021 ·
SAVA Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Cassava Sciences, Inc. of Deadline in Securities Fraud Class Action Lawsuit
· Persbericht
3 september 2021 ·
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc. - SAVA
· Persbericht
1 september 2021 ·
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. (SAVA) Investors with Losses to Contact Firm's Attorneys Now, Securities Fraud Class Period Expanded
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe